Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From the coconut farms of the Philippines to refrigerators across the U.S., Vita Coco turns raw coconuts into a global hydration franchise. That supply chain鈥攁nd the social commitments behind it鈥攕urface in every SEC document. If you鈥檝e searched for 鈥淰ita Coco SEC filings explained simply鈥� or wondered how sustainability costs flow through the P&L, this page delivers the answers.
Here you will find the 鈥淰ita Coco annual report 10-K simplified鈥� to track segment growth in The Americas, the 鈥淰ita Coco quarterly earnings report 10-Q filing鈥� that reveals coconut cost inflation, and the 鈥淰ita Coco 8-K material events explained鈥� whenever sourcing disruptions arise. Need to monitor management moves? Our dashboard surfaces 鈥淰ita Coco insider trading Form 4 transactions,鈥� 鈥淰ita Coco Form 4 insider transactions real-time,鈥� and 鈥淰ita Coco executive stock transactions Form 4鈥� the moment they hit EDGAR. Corporate governance questions? Scan the 鈥淰ita Coco proxy statement executive compensation鈥� to see how bonus targets align with carbon reduction goals. Each document includes concise summaries and real-time alerts.
Stock Titan鈥檚 AI distills every note into clear language, so 鈥渦nderstanding Vita Coco SEC documents with AI鈥� means you can jump straight to coconut-water revenue, cash flow, or sustainability metrics. Receive instant notifications, compare 鈥淰ita Coco earnings report filing analysis鈥� quarter over quarter, and export numbers directly to your models. Save hours and make confident decisions with complete, up-to-date information.
Corey Baker, Chief Financial Officer of Vita Coco Company, Inc. (COCO), reported two sales of common stock under a Rule 10b5-1 plan. The filings show a sale of 1,000 shares on 09/05/2025 at $38.00 and a sale of 1,000 shares on 09/08/2025 at $38.51, reducing his beneficially owned common stock to 41,754 shares. The report also lists outstanding non-qualified stock options exercisable into common stock: 14,205 shares at a $16.91 strike, 13,481 at $24.35, 8,746 at $26.18, 11,547 at $27.59 and 13,218 at $33.36, each held directly. Several option grants have scheduled vesting dates and installment vesting schedules as described by the reporting person.
The Vita Coco Company, Inc. (COCO) filed a Form 144 reporting a proposed sale of 50,000 common shares. The shares are to be sold through Morgan Stanley Smith Barney LLC with an approximate sale date of 09/09/2025 and an aggregate market value of $1,919,500. The filer acquired these shares as founders' shares on 09/10/2010. There are 56,822,981 shares outstanding per the form. The filing states no securities were sold by the filer in the past three months and includes the standard representation that the selling person does not possess undisclosed material adverse information.
The Vita Coco Company, Inc. (COCO) submitted a Form 144 reporting proposed and recent insider sales. The filer reported a proposed sale of 4,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $154,160, planned for 09/08/2025 on NASDAQ. Those 4,000 shares were acquired as restricted stock units on 03/10/2025. The filing also discloses a prior 10b5-1 sale of 1,000 shares by Corey Baker on 09/05/2025 generating $38,000 in gross proceeds. The notice includes the required attestation regarding material nonpublic information.
Vita Coco Company director Ira Liran reported sales of common stock under a Rule 10b5-1 trading plan. On 09/03/2025 he disposed of 14,734 shares at a weighted-average price of $37.052 per share and on 09/04/2025 he disposed of 2,114 shares at a weighted-average price of $37.001 per share, for a total of 16,848 shares sold. Following these transactions the filing shows 618,341 shares held directly and 782,579 shares held indirectly through the Ira Liran 2012 Family Trust. The filing was signed by Alison Klein, attorney-in-fact, on 09/05/2025.
Form 144 notice for The Vita Coco Company, Inc. (COCO) reports a proposed sale of 1,000 common shares through Morgan Stanley Smith Barney LLC on 09/05/2025 on NASDAQ with an aggregate market value of $37,250.00. The shares represent restricted stock units acquired from the issuer on 03/10/2025, with payment recorded on the same date. The filing indicates 56,822,981 shares outstanding for the class. No securities were reported sold by the same person in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information. Several filer and issuer identifying details (names, CIK, contact) are not provided in the visible content.
Ira Liran, a director of Vita Coco Company, Inc. (COCO), reported the sale of 3,152 shares of company common stock on 08/22/2025 under a Rule 10b5-1 trading plan at a weighted average price of $37.022 per share. Following the transaction, Mr. Liran directly beneficially owns 635,189 shares and indirectly beneficially owns 782,579 shares through the Ira Liran 2012 Family Trust. The filing was submitted by an attorney-in-fact on behalf of the reporting person on 08/25/2025 and includes an undertaking to provide detailed per-price sale information on request.
Kenneth Sadowsky, a director of The Vita Coco Company, Inc. (COCO), sold 3,900 shares of common stock under a Rule 10b5-1 trading plan on 08/20/2025 at a weighted average price of $35.448, with transaction prices ranging from $34.91 to $35.78. After the sale he beneficially owned 627,766 shares directly. The filing also reports a fully vested non-qualified stock option with a $10.178 exercise price covering 27,300 shares, exercisable through 01/02/2030. The Form 4 was signed by Alison Klein as attorney-in-fact on 08/22/2025. The filing indicates the sale was effected pursuant to a pre-established trading plan and discloses the weighted average and price range for the multiple trades executed.
Ira Liran, a director of Vita Coco Company, Inc. (COCO), reported the sale of 30,000 shares of common stock on 08/20/2025 under a Rule 10b5-1 trading plan at a weighted average price of $36.08 per share. The filing states the shares were sold in multiple transactions at prices ranging from $36.00 to $36.30 and that the sold shares are held by the Ira Liran 2012 Family Trust.
After the reported transactions the filing discloses beneficial holdings of 782,579 shares indirectly by the Ira Liran 2012 Family Trust and 638,341 shares directly. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Liran and indicates the sale was made pursuant to an established trading plan.
The filing is a Form 144 notice regarding proposed sale of common stock of The Vita Coco Company, Inc. (COCO). It discloses a proposed sale of 140,000 shares of common stock through The Charles Schwab Corporation on NASDAQ with an approximate aggregate market value of $6,040,000 and an approximate sale date of 08/22/2025. The filing reports 56,822,981 shares outstanding.
The shares to be sold were acquired as stock compensation on 08/11/2009 (140,000 shares). The form also records a recent sale by the same account: 30,000 shares sold on 08/20/2025 for gross proceeds of $1,082,391. Several form sections (filer identity and relationship to issuer) are not populated in the provided content.
Form 144 filing for The Vita Coco Company, Inc. (COCO) reports a proposed sale of 210,000 common shares through Charles Schwab, with an aggregate market value of $8,862,391.00. The filer acquired these shares on 08/11/2009 as stock compensation from the issuer. The filing lists 56,822,981 shares outstanding and an approximate sale date of 08/20/2025. The notice states no securities were sold by the account in the past three months and includes the filer鈥檚 representation about absence of undisclosed material adverse information.
FAQ
What is the current stock price of Vita Coco Company (COCO)?
What is the market cap of Vita Coco Company (COCO)?
